Viewing Study NCT02634827

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:18 AM
Ignite Modification Date: 2026-03-01 @ 4:19 AM
Study NCT ID: NCT02634827
Status: TERMINATED
Last Update Posted: 2019-08-07
First Post: 2015-12-16
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia With FLT3/ITD Mutation View
None Acute Myeloid Leukemia With Gene Mutations View
None FLT3 Tyrosine Kinase Domain Point Mutation View
None Secondary Acute Myeloid Leukemia View
None Untreated Adult Acute Myeloid Leukemia View
Keywords: